Full Breakdown
FDA’s Operation Stork Speed Finds U.S. Infant Formula Largely Free of Harmful Contaminants
4/30/2026, 7:55:41 AM
Background & Context
Operation Stork Speed was launched in March 2025 by the Trump administration to overhaul safety and quality standards for infant formula. The initiative followed a 2022 nationwide formula shortage, a 2023 ByHeart botulism recall, and a Consumer Reports analysis that flagged “worrisome” heavy-metal levels in many U.S. brands.
Scope and Findings
Between 2023 and 2025 the FDA purchased 312 samples from 16 commercial brands sold nationwide and tested them for lead, arsenic, cadmium, mercury, glyphosate, glufosinate, phthalates, and 30 PFAS compounds. All heavy-metal concentrations were below EPA drinking-water limits; 99 % of samples showed no detectable pesticides; 95 % had PFAS <= 28 ppt, with 25 of 30 PFAS compounds undetected. Low-level phthalates appeared in a few products.
Official Statements & Responses
FDA food chief Kyle Diamantas said the testing “reinforces that infant formula in the US is a safe option” and pledged to keep driving contaminants “as low as possible.” HHS Secretary Robert F. Kennedy Jr. promised “honest, transparent data” and accountability for manufacturers. FDA Commissioner Marty Makary highlighted ongoing oversight and additional testing. Abbott Nutrition and Bobbie CEO Laura Modi welcomed the results and urged the agency to set formal contaminant limits.
Why It Matters
Even modest exposure to lead, mercury, cadmium or arsenic can impair brain development, learning and behavior in infants. Because the domestic formula supply is deemed a matter of national security, confirming its safety has broad public-health and supply-chain implications.
Criticism & Opposition
Pediatrics professor Sheela Sathyanarayana warned that “any detection of PFAS or phthalates is problematic” and called for stricter monitoring. Consumer-advocacy groups note that the United States lacks enforceable contaminant limits, unlike the EU, Canada and Australia, and urge the FDA to codify health-based standards.
Conflicting Reports & Gaps
The testing program did not assess microbiological hazards such as botulism, which caused past recalls, nor did it evaluate contaminants that triggered earlier shortages. Moreover, the FDA applied EPA drinking-water limits as a proxy because no federal formula-specific limits exist, leaving uncertainty about acceptable exposure thresholds.
Verbatim Quotes
- “This testing — the first of its kind — reinforces that infant formula in the US is a safe option for parents and caregivers who rely on it,” — Kyle Diamantas, FDA food chief
- “We tested more infant formula than ever before, and the results are clear: most products meet a high safety standard — but even small exposures matter for newborns,” — Robert F. Kennedy Jr., HHS Secretary
- “There’s no reason not to use any available formula” — Steven Abrams, professor of pediatrics, University of Texas at Austin
- “Any detection of PFAS or phthalates is problematic" and deserves scrutiny, especially in products that babies consume, Dr.” — Sheela Sathyanarayana, professor of pediatrics, University of Washington
What’s Next
In May, Secretary Kennedy will convene a roundtable with executives from Abbott, Reckitt Benckiser, Perrigo, Bobbie and other manufacturers to discuss modernizing FDA oversight and establishing federal contaminant limits. The agency has announced continued sampling, expanded testing for additional chemicals, and a plan to publish periodic results to maintain transparency.
